Skip to main content
. 2024 Apr 29;23:147. doi: 10.1186/s12933-024-02240-z

Table 2.

Laboratory characteristics

Data Total Group 1 T2DM Group 2 Non T2DM p-value
[N = 1706] [N = 680] [N = 1026]
Hemoglobin [mmol/L] 7.7 ± 1.4 7.5 ± 1.5 7.9 ± 1.4  < 0.001
Hematocrit [%] 36 ± 1 35 ± 1 37 ± 1  < 0.001
Erythrocytes [× 106/μL] 4.1 ± 0.7 4.0 ± 0.7 4.1 ± 0.6  < 0.001
Leukocytes [× 103/μL] 7.3 ± 2.3 7.1 ± 2.1 7.5 ± 2.4  < 0.001
Platelets [× 103/μL] 198 ± 64 191 ± 65 204 ± 63  < 0.001
Total cholesterol [mg/dL] 198 ± 57 179 ± 53 210 ± 56  < 0.001
HDL-C [mg/dL] 52 ± 16 49 ± 15 53 ± 16  < 0.001
LDL-C [mg/dL] 121 ± 51 103 ± 48 132 ± 50  < 0.001
Triglycerides [mg/dL] 134 ± 79 138 ± 76 131 ± 81 0.001
Fasting glucose (mg/dL) 158 ± 72 190 ± 86 136 ± 50  < 0.001
Creatinine [mg/dL] 1.3 ± 0.8 1.4 ± 1.0 1.2 ± 0.8  < 0.001
eGFR CKD-EPI 64 ± 23 57 ± 23 69 ± 21  < 0.001
Max CK-MB level [ng/mL] 80 ± 104 61 ± 89 93 ± 112  < 0.001
Max troponin level [pg/mL] 312 ± 1391 186 ± 1106 394 ± 1544 0.007

Data are presented as mean ± SD

(HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, eGFR CKD-EPI estimated glomerular filtration rate Chronic Kidney Disease Epidemiology Collaboration, CK-MB creatine kinase myocardial band isoenzyme)